American Association for the Advancement of Science, Science, 6349(357), p. 358-358, 2017
DOI: 10.1126/science.aao1894
Export citation
Search in Google Scholar
Full text: Unavailable
A tumor-associated defect can identify patients to receive immune checkpoint therapy